CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium

Journal of Neuroimmunology

Volumn 134, Issue 1-2, 2003, Pages 166-178

  Omari, Kakuri M ^a   Dorovini Zis, Katerina ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adhesion; CD4+ T cells; CD40; CD40L; Cell adhesion molecules; Cerebral endothelium

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL STIMULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; T LYMPHOCYTE; UPREGULATION;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; BLOOD-BRAIN BARRIER; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICROSCOPY, ELECTRON; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037218982     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00423-X     Document Type: Article

References (67)

1. Abdel-Haq N., Hao H.N., Lyman W.D. Cytokine regulation of CD40 expression in fetal human astrocyte cultures. J. Neuroimmunol. 101:1999;7-14.
2. Archellos J.J., Jung S., Mäurer M., Schmied M., Lassmann H., Tamatani T., Miyaska M., Toyka K.V., Hartung H.P. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
3. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of α4 integrin by CD4 T cells is required for their entry into the brain parenchyma. J. Exp. Med. 177:1993;57-68.
4. Becher B., Blain M., Antel J.P. CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J. Neuroimmunol. 102:2000;44-50.
5. Becher B., Durell B.G., Miga A.V., Hickey W.F., Noelle R.J. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193:2001;967-974.
6. Boon L., Brok H.P., Bauer J., Ortiz-Buijsse A., Schellekens M.M., Ramdien-Murli S., Blezer E., van Meurs M., Ceuppens J., de Boer M., t Hart B.A., Laman J.D. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J. Immunol. 167:2001;2942-2949.
7. Caux C., Massacrier C., Vanbervliet B., Dubois B., van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1994;1263-1272.
8. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:1996;747-752.
9. 14C-labelled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:1990;162-170.
10. D'Aversa T.G., Weidenheim K.M., Berman J.W. CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am. J. Pathol. 160:2002;559-567.
11. Dechanet J., Grosset C., Taupin J.L., Merville P., Banchereau J., Ripoche J., Moreau J.F. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J. Immunol. 159:1997;5640-5647.
12. de Goer de Herve M.G., Delfraissy J.F., Taoufik Y. Following direct CD40 activation, human primary microglial cells produce IL-12 p40 but not bioactive IL-12 p70. Cytokine. 14:2001;88-96.
13. Dorovini-Zis K., Prameya R., Bowman P.D. Culture and characterization of microvascular endothelial cells derived from human brain. Lab. Invest. 64:1991;425-436.
14. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., Noelle R.J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1993;1328-1330.
15. Durie F.H., Aruffo A., Ledbetter J., Crassi K.M., Green W.R., Fast L.D., Noelle R.J. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1994;1333-1338.
16. Evans D.E., Munks M.W., Purkerson J.M., Parker D.C. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J. Immunol. 164:2000;688-697.
17. Gaweco A.S., Wiesner R.H., Yong S., Krom R., Porayko M., Chejfec G., McClatchey K.D., van Thiel D.H. CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection. Liver Transplant. Surg. 5:1999;1-7.
18. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2499-2504.
19. Graf D., Muller S., Korthauer U., van Kooten C., Weise C., Kroczek R.A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25:1995;1749-1754.
20. Grell M., Wajant H., Zimmermann G., Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. U. S. A. 95:1998;570-575.
21. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Janeway C.A. Jr., Flavell R.A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1996;1864-1867.
22. Hauser S.L., Bhan A.K., Gilles F., Kemp M., Kerr C., Weiner H.L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19:1986;578-587.
23. Henn V., Slupsky J.R., Gräfe M., Anagnostopoulos I., Förster R., Müller-Berghaus G., Kroczek R.A. CD40 ligand on activated platelets trigger an inflammatory reaction on endothelial cells. Nature. 39:1998;591-594.
24. Hermann P., Blanchard D., de Saint-Vis B., Fossiez F., Gaillard C., Vanbervliet B., Briere F., Banchereau J., Galizzi J.P. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur. J. Immunol. 23:1993;961-964.
25. Hickey W.F., Lassmann H., Cross A.N. Lymphocyte entry and the initiation of inflammation in the central nervous system. Keane R.W., Hickey W.F. Immunology of the Nervous System. 1997;200-225 Oxford Univ. Press, New York.
26. Hollenbaugh D., Mischel-Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A., Aruffo A. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:1995;33-40.
27. Howard L.M., Miga A.J., Vanderlugt C.L., Dal Canto M.C., Laman J.D., Noelle R.J., Miller S.D. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103:1999;281-290.
28. Howard L., Dal Canto M., Miller S. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses. J. Neuroimmunol. 129:2002;58-65.
29. Huynh H.K., Dorovini-Zis K. Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells. Am. J. Pathol. 142:1993;1265-1278.
30. Jollow K.C., Zimring J.C., Sundstrom J.B., Ansari A.A. CD40 ligation induced phenotypic and functional expression of CD80 by human cardiac microvascular endothelial cells. Transplantation. 68:1999;430-439.
31. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U. S. A. 92:1995;4342-4346.
32. Karmann K., Min W., Fanslow W.C., Pober J.S. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J. Exp. Med. 184:1996;173-182.
33. Karpusas M., Hsu Y.M., Wang J.H., Thompson J., Lederman S., Chess L., Thomas D. 2 Å crystal structure of an extracellular fragment of human CD40 ligand. Structure. 3:1995;1031-1039.
34. Kato K., Santana-Sahagun E., Rassenti L.Z., Weisman M.H., Tamura N., Kobayashi S., Hashimoto H., Kipps T.J. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J. Clin. Invest. 104:1999;947-955.
35. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:1995;4917-4925.
36. Kotowicz K., Dixon G.L.J., Klein N.J., Peters M.J., Callard R.E. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology. 100:2000;441-448.
37. Kyburz D., Corr M., Brinson D.C., Damm A.V., Tighe H., Carson D.A. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J. Immunol. 163:1999;3116-3122.
38. Laschinger M., Engelhardt B. Interaction of α4-intergrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 102:2000;32-43.
39. Lutgens E., Gorelik L., Daeman M.F.A.P., de Muinck E.D., Grewal I.S., Koteliansky V.E., Flavell R.A. Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5:1999;1313-1316.
40. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394:1998;200-203.
41. Mach F., Schönbeck U., Fabunmi R.P., Murphy C., Atkinson E., Bonnefoy J.Y., Graber P., Libby P. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependant mechanism. Am. J. Pathol. 154:1999;229-238.
42. Miller D.L., Yaron R., Yellin M.J. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J. Leukoc. Biol. 63:1998;373-379.
43. Mohan C., Shi Y., Laman J.D., Datta S.K. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1995;1470-1480.
44. Omari K.I.M., Dorovini-Zis K. Expression and function of lymphocyte function associated antigen-3 (LFA-3) at the blood-brain barrier. Cell. Mol. Biol. 45:1999;25-35.
45. Omari K.I.M., Dorovini-Zis K. Expression and function of the costimulatory molecules B7-1 (CD80) and B7-2 (CD86) in an in vitro model of the human blood-brain barrier. J. Neuroimmunol. 113:2001;129-141.
46. Pammer J., Plettenberg A., Weninger W., Diller B., Mildner M., Uthman A., Issing W., Sturzl M., Tschachler E. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol. 148:1996;1387-1396.
47. Ranheim E.A., Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:1993;925-935.
48. Reiss Y., Hoch G., Deutsch U., Engelhard B. T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur. J. Immunol. 28:1998;3086-3099.
49. Reul R.M., Fang J.C., Denton M.D., Geehan C., Long C., Mitchell R.N., Ganz P., Briscoe D.M. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograph rejection. Transplantation. 64:1997;1765-1774.
50. Saito K., Sakurai J., Ohata J., Kohsaka T., Hashimoto H., Okumura K., Abe R., Azuma M. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J. Immunol. 160:1998;4225-4231.
51. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58:2001;4-43.
52. Singh S.R., Casper K., Summers S., Swerlick R.A. CD40 expression and function on human dermal microvascular endothelial cells: role in cutaneous inflammation. Clin. Exp. Dermatol. 26:2001;434-440.
53. Smith T.J., Sciaky D., Phipps R.P., Jennings T.A. CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases. Thyroid. 9:1999;749-755.
54. Steffen B., Butcher E.C., Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in SJL/J mouse. Am. J. Pathol. 145:1994;189-201.
55. Tan J., Town T., Paris D., Mori T., Suo Z., Crawford F., Mattson M.P., Flavell R.A., Mullan M. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science. 286:1999;2352-2355.
56. Tan J., Town T., Mori T., Obregon D., Wu Y., DelleDonne A., Rojiani A., Crawford F., Flavell R.A., Mullan M. CD40 is expressed and functional on neuronal cells. EMBO J. 21:2002;643-652.
57. Thienel U., Loike J., Yellin M.J. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Cell. Immunol. 198:1999;87-95.
58. Togo T., Akiyama H., Kondo H., Ikeda K., Kato M., Iseki E., Kosaka K. Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. Brain Res. 885:2000;117-121.
59. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67:2000;2-17.
60. Wagner A.H., Gebauer M., Pollok-Kopp B., Hecker M. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood. 99:2002;520-525.
61. Wong D., Dorovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39:1992;11-21.
62. Wong D., Dorovini-Zis K. Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture. Microvasc. Res. 49:1995;325-339.
63. Wong D., Dorovini-Zis K. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) expression by human brain microvessel endothelial cells in primary culture. Brain Res. 731:1996;217-220.
64. Wong D., Dorovini-Zis K. Regualtion by cytokines and lipopolysaccharide of E-selectin expression by human brain microvessel endothelial cells in primary culture. J. Neuropathol. Exp. Neurol. 55:1996;225-235.
65. Wong D., Prameya R., Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM- 1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58:1999;138-152.
66. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies again α4β1 intergrin. Nature. 356:1992;63-66.
67. Yellin M.J., Brett J., Baum D., Matsushima A., Szabolcs M., Stern D., Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182:1995;1857-1864.